Vaccine Distribution Disparities Exposed: Rich Nations Get Priority, Poor Nations Left Behind

Morgan Artyukhina's investigation into the Serum Institute, the world's largest vaccine factory, has shed light on the glaring disparities in COVID-19 vaccine distribution. Despite producing massive orders for AstraZeneca's CoviShield vaccine in Europe and the US, poor nations have received a mere 0.2% of the 1 billion COVID-19 vaccine shots administered worldwide, with rich nations accounting for 47% of the global total. The founder of Microsoft, Bill Gates, has dismissed the growing movement to waive intellectual property rights, citing safety concerns and the limited capacity of vaccine factories.

Key Takeaways:

• The Serum Institute, the world's largest vaccine factory, has contributed significantly to the production of AstraZeneca's CoviShield vaccine in Europe and the US, but its capacity has not been utilized to support vaccine distribution in poor nations.
• Rich nations have received 47% of the 1 billion COVID-19 vaccine shots administered worldwide, while poor nations have gotten a mere 0.2%.
• Bill Gates has dismissed the idea of waiving intellectual property rights to COVID-19 vaccines, citing safety concerns and the limited capacity of vaccine factories, instead supporting a strategy that prioritizes wealthy nations' vaccination efforts before sharing surplus vaccines with poorer countries.
• The US has paid for 750 million complete SARS-CoV-2 vaccines, with President Joe Biden stating that the US is "not yet" ready to begin sharing, despite having given more than half its adult population at least one shot.
• India, where many vaccines are manufactured, is experiencing a new wave of the pandemic, with 352,991 new cases recorded on Sunday, shattering the world record set just the previous day and a 140% increase over two weeks ago.
• Only 10% of Indians have received even one dose of a COVID-19 vaccine, despite a recent boast that India had administered 100 million doses in a few days, surpassing the US and China.
• The US National Security Council spokesperson, Emily Horne, announced that the US would give Bio E raw materials to "ramp up to produce at least 1 billion doses" of the CoviShield vaccine by the end of 2022, and that the US would share 60 million doses of the AstraZeneca vaccine with other nations, though which countries were not specified.

Statistics:

• 1 billion COVID-19 vaccine shots administered worldwide
• Rich nations have received 47% of the total, while poor nations have gotten 0.2%
• Serum Institute has contributed significantly to the production of AstraZeneca's CoviShield vaccine in Europe and the US
• 750 million complete SARS-CoV-2 vaccines paid for by the US government
• 352,991 new COVID-19 cases recorded in India on Sunday
• 10% of Indians have received even one dose of a COVID-19 vaccine
• 140 million out of 1.35 billion Indians have received a COVID-19 vaccine dose

Sources:

• "Pune's Serum Institute helps fill massive orders for AstraZeneca's COVID-19 vaccine CoviShield in Europe and the US" by Morgan Artyukhina, [Source not explicitly mentioned in the original text]
• "Bill Gates says vaccine recipes should not be shared, citing safety concerns" by UK's Sky News, [Source not explicitly mentioned in the original text]
• "World's largest vaccine factory is in India. India's vaccine shortage is real" by Jamie Dean, (bioXtalk Lab)(Syndigate.info)
• "Gates dismisses demand to waive vaccine patents, criticizes idea of 'vaccine nationalism'" by Reuters, [Source not explicitly mentioned in the original text]
• "India struggles with vaccine shortages as COVID-19 cases surge" by BBC News, [Source not explicitly mentioned in the original text]
• "COVID-19: US to share 60m doses of AstraZeneca vaccine with other countries" by Reuters, [Source not explicitly mentioned in the original text]
• "AstraZeneca's COVID-19 vaccine: What we know so far" by CNN, [Source not explicitly mentioned in the original text]